Table 9.6c

Immunosuppression Use: Maintenance Between Discharge

and One Year Posttransplant, 1993 to 2002

Recipients with Liver Transplants

		Year of Transplant
		1993	1994	1995	1996	1997	1998	1999	2000	2001	2002
Transplants		3,440	3,652	3,934	4,080	4,187	4,516	4,749	4,989	5,188	5,330
Tx With Follow-up Immunosuppression Info		2,634	2,860	3,131	3,175	3,356	3,668	3,804	4,102	4,297	4,530
Corticosteroids	Category Usage	97.8%	98.2%	96.7%	95.1%	94.9%	92.8%	90.7%	90.4%	89.4%	87.2%
	Steroids	97.8%	98.2%	96.7%	95.1%	94.9%	92.8%	90.7%	90.4%	89.4%	87.2%
Cyclosporine	Category Usage	80.1%	66.1%	50.1%	42.4%	39.7%	33.6%	30.9%	23.5%	18.4%	14.1%
	Cyclosporin	79.9%	62.0%	25.7%	0.0%	0.0%	0.0%	0.1%	0.1%	0.0%	0.0%
	Sandimmmune	2.8%	6.0%	16.9%	8.9%	5.9%	7.3%	7.1%	5.6%	3.6%	2.1%
	Neoral	0.3%	3.1%	28.6%	37.3%	36.4%	29.4%	26.9%	20.3%	15.2%	10.5%
	Gengraf	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.1%	1.0%	2.0%	2.5%
	Eon	0.0%	0.0%	0.0%	0.0%	0.0%	0.1%	0.0%	0.2%	0.7%	0.3%
Tacrolimus	Category Usage	25.5%	43.6%	57.3%	64.3%	66.3%	73.3%	77.8%	83.8%	88.8%	90.2%
	FK506	25.5%	43.6%	57.3%	64.3%	66.3%	73.3%	77.8%	83.8%	88.8%	90.2%
Antimetabolites	Category Usage	58.2%	49.0%	43.8%	44.5%	43.9%	39.8%	49.4%	51.9%	53.0%	53.1%
	Azathioprine	57.4%	47.4%	33.5%	20.8%	17.7%	10.3%	8.3%	5.9%	4.5%	4.3%
	Mycophenolate mofetil	0.6%	1.7%	12.3%	24.9%	29.7%	31.5%	43.0%	47.4%	49.9%	50.3%
	Leflunomide	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.1%	0.0%	0.0%	0.0%
	Cytoxan	0.5%	0.4%	0.4%	0.3%	0.4%	0.1%	0.2%	0.4%	0.1%	0.1%
Other	Category Usage	0.0%	0.0%	0.0%	0.0%	0.0%	1.2%	3.1%	15.2%	16.8%	14.0%
	Rapamycin	0.0%	0.0%	0.0%	0.0%	0.0%	1.2%	3.1%	15.2%	16.8%	14.0%

Source: OPTN/SRTR Data as of May 3, 2004.

Individual drug percentages will not necessarily add up to the drug category percentages, as patients may

be prescribed more than one drug within the same category.